glp‑1 receptor agonists - Weight Loss Facts

GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity, finds small trial — Phot

glp‑1 receptor agonists

Why Obesity Treatment Is Missing A Solution

Obesity treatment often misses a solution because it does not target the 30% reduction in heavy drinking days that GLP-1 therapies can achieve alongside weight loss. A recent 12-week cohort of 86 patients showed both fewer drinking episodes and a modest 6% drop in BMI, suggesting a dual-action approach. Medical